The Magna Græcia University of Catanzaro is a university located in Catanzaro, Italy. It was founded in 1998 and is organized in three faculties.

During the past decade, University Magna Graecia of Catanzaro conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 3 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Magna Graecia of Catanzaro" #1 sponsor was "University Magna Graecia" with 12 trials, followed by "University of Catanzaro" with 11 trials sponsored, "Societa Italiana di Chirurgia ColoRettale" with 2 trials sponsored, "University of Messina" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Magna Graecia of Catanzaro" #1 collaborator was "Ministry of Education, Universities and Research, Italy" with 2 trials as a collaborator, "Alberto Realis Luc" with 1 trials as a collaborator, "Alessandro Sturiale" with 1 trials as a collaborator, "Cardiovascular Research Foundation, New York" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University Magna Graecia of Catanzaro" are "Endometriosis" (4 trials), "Uterine Fibroids" (4 trials), "Pelvic Pain" (3 trials), "Metabolic Syndrome" (2 trials) and "Polycystic Ovary Syndrome" (2 trials). Many other conditions were trialed in "University Magna Graecia of Catanzaro" in a lesser frequency.

Most popular intervention types in "University Magna Graecia of Catanzaro" are "Drug" (11 trials), "Procedure" (7 trials), "Diagnostic Test" (5 trials), "Other" (5 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "In-office vascular visit" (2 trials), ""model 1000 PNT vacuum controller" (the vacuum device for ocular suction)" (1 trials), "ABSORB scaffold" (1 trials) and "Butter supplementation" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Magna Graecia of Catanzaro" are 24 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Magna Graecia of Catanzaro". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in University Magna Graecia of Catanzaro, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University Magna Graecia of Catanzaro, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 7 trials that are defined as “Not Applicable".